Lumos Diagnostics Holdings Limited
LDXHF
$0.115
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.40% | 30.13% | 43.50% | 23.70% | 4.22% |
| Total Depreciation and Amortization | -6.27% | -15.69% | -22.76% | -33.04% | -41.09% |
| Total Amortization of Deferred Charges | -37.25% | -4.89% | 40.60% | 40.60% | 40.60% |
| Total Other Non-Cash Items | -24.14% | -284.08% | -581.77% | -2,650.00% | 233.79% |
| Change in Net Operating Assets | -200.41% | -101.49% | 237.53% | 237.53% | 237.53% |
| Cash from Operations | -1,086.68% | -29.81% | 93.81% | 102.29% | 109.82% |
| Capital Expenditure | -1.92% | 32.34% | 47.83% | 53.33% | 58.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 39.34% | -146.67% | -84.44% | -53.33% |
| Cash from Investing | 45.92% | -103.54% | -102.24% | -102.26% | -102.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 60.07% | 59.85% | 59.65% | 22.17% | -29.52% |
| Issuance of Common Stock | 26.40% | 26.40% | 26.40% | 126.40% | -- |
| Repurchase of Common Stock | -53.82% | -153.82% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 60.99% | 60.99% | 69.40% | 100.00% |
| Cash from Financing | 100.61% | 38.13% | 4.98% | 39.67% | 303.37% |
| Foreign Exchange rate Adjustments | -2,842.86% | -413.50% | -185.23% | -1.39% | 95.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -230.57% | -109.11% | 596.81% | 274.42% | 169.80% |